Compelling New Clinical Data for TissuePatch™ in Head & Neck surgeryMay 8, 2017
Surgeons from the Barts Health Trust and Homerton University Hospital in London, UK, recently presented new data in an ongoing retrospective analysis of the use of TissuePatch™ surgical sealant film to prevent post-operative bleeding after thyroid surgery. Find the e-poster here in our ‘Resource’ page. Titled “The use of TissuePatch, a self-adhesive sealant film to prevent post-operative vascular leakage after thyroid surgery,” the poster was presented during the 23rd International Conference on Oral and Maxillofacial Surgery (ICOMS), in Hong Kong, 31st March-3rd April 2017.
The latest data – almost twice the original cohort, from in excess of 50 patients treated with TissuePatch™, demonstrated that drainage volume and length of patient stay were both lower compared with this centre’s comparative data when TissuePatch™ wasn’t used.
The mean length of stay for patients treated with TissuePatch™ was 1.6 days, compared to 3 days for the historic control patients. Furthermore, the average drainage volumes were 39.2ml and 60ml respectively.
The authors reported that no patients required blood transfusion or suffered post-operative haematoma.
Leo Cheng, lead investigator concluded; “We have found that the use of TissuePatch™ was a safe and effective adjunct to ensure an effective seal to potential sources of oozing or bleeding from the operative site.”
David Mandley for Tissuemed remarked; “This latest data from Leo Cheng’s team, is an excellent addition to the growing clinical evidence supporting the use of the TissuePatch™ product family as a surgical sealant film to prevent intra- and post-operative leaks. In parallel with a clear reduction in drainage volumes, patients were on average discharged a day earlier when TissuePatch™ was used.”